ITTO20100237A1 - WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION - Google Patents

WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION

Info

Publication number
ITTO20100237A1
ITTO20100237A1 IT000237A ITTO20100237A ITTO20100237A1 IT TO20100237 A1 ITTO20100237 A1 IT TO20100237A1 IT 000237 A IT000237 A IT 000237A IT TO20100237 A ITTO20100237 A IT TO20100237A IT TO20100237 A1 ITTO20100237 A1 IT TO20100237A1
Authority
IT
Italy
Prior art keywords
antinfluenous
immunoglobulines
medication
whole
igg class
Prior art date
Application number
IT000237A
Other languages
Italian (it)
Inventor
Roberto Burioni
Massimo Clementi
Original Assignee
Pomona Biotechnologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomona Biotechnologies Llc filed Critical Pomona Biotechnologies Llc
Priority to IT000237A priority Critical patent/ITTO20100237A1/en
Priority to PCT/IB2011/051284 priority patent/WO2011117848A1/en
Priority to CN201180015849.0A priority patent/CN102958539B/en
Priority to US13/637,030 priority patent/US20130022608A1/en
Priority to EP11721645.7A priority patent/EP2552485B1/en
Priority to SI201131130A priority patent/SI2552485T1/en
Priority to HRP20170490TT priority patent/HRP20170490T1/en
Priority to EA201290955A priority patent/EA029198B1/en
Publication of ITTO20100237A1 publication Critical patent/ITTO20100237A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
IT000237A 2010-03-26 2010-03-26 WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION ITTO20100237A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT000237A ITTO20100237A1 (en) 2010-03-26 2010-03-26 WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION
PCT/IB2011/051284 WO2011117848A1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
CN201180015849.0A CN102958539B (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the IgG isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
US13/637,030 US20130022608A1 (en) 2010-03-26 2011-03-25 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF
EP11721645.7A EP2552485B1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
SI201131130A SI2552485T1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
HRP20170490TT HRP20170490T1 (en) 2010-03-26 2011-03-25 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
EA201290955A EA029198B1 (en) 2010-03-26 2011-03-25 FULL-DIMENSIONAL IGG ISOTYPE IMMUNOGLOBULINS, CAPABLE FOR RECOGNITION OF NEUTRALIZING EPITOPE IN THE STEM OF HEMAGGLUTININ STEM OF DIFFERENT SUBTIPS AND THEIR USE THEMES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000237A ITTO20100237A1 (en) 2010-03-26 2010-03-26 WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION

Publications (1)

Publication Number Publication Date
ITTO20100237A1 true ITTO20100237A1 (en) 2011-09-27

Family

ID=42938492

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000237A ITTO20100237A1 (en) 2010-03-26 2010-03-26 WHOLE IMMUNOGLOBULINES OF THE IGG CLASS FOR USE AS AN ANTINFLUENOUS MEDICATION

Country Status (1)

Country Link
IT (1) ITTO20100237A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115972A1 (en) * 2008-03-17 2009-09-24 Pomona Biotechnologies Llc Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115972A1 (en) * 2008-03-17 2009-09-24 Pomona Biotechnologies Llc Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes

Similar Documents

Publication Publication Date Title
EP2768531A4 (en) MEGANLUMIN STABILIZED STERILE FORMANTIONS
IL238784A0 (en) Adjuvants for the treatment of diseases caused by psma-expressing cells
EP2935321A4 (en) CHIMERIC ANTIGEN RECEPTORS
DK3195880T3 (en) Highly Concentrated Anti-Sclerostin Antibody Formulations
EP2704573A4 (en) AMINOMETHYL-BIARYL-BENZOTRIAZOLE DERIVATIVES
EP2866833A4 (en) CRYSTALLINE ANTI-HUMAN IL-23 ANTIBODIES
EP2968553A4 (en) ANTIBODY FORMULATIONS
IL227990B (en) Use of 3-(5-amino-2-methyl-4-oxoquinlosin-3-(4h)-yl)piperidine-2,6-dinone for the preparation of drugs for the treatment of diseases related to the immune system and inflammatory diseases
EP2802850C0 (en) ANASTIGMATIC IMAGING SPECTROGRAPH
DK3091029T5 (en) Anti-IL13 antibody formulations
EP2895500A4 (en) IMMUNOGENS INDUCING ANTIBODIES
EP2918242A4 (en) ORAL HYGIENE DEVICE
SI3513806T1 (en) The composition of the immunogen
SMT201500057B (en) Use of biotin for the treatment of multiple sclerosis
IT1402018B1 (en) FORMULATIONS FOR THE TREATMENT OF THE AFFECTIONS OF THE FIRST RESPIRATORY ROUTES.
PT4417216T (en) Stable formulations of RLP2086 antigens from Neisseria meningitidis
FR2962650B1 (en) COMPOSITION OF HUMAN CONCENTRATED IMMUNOGLOBULINS
BR112012031861A2 (en) use of 5a-androstane (alkyl) -3b, 5,6b-triol
EP2721029A4 (en) IMIDAZOPYRIDIN-2-ONE DERIVATIVES
DK3498313T3 (en) TUBULAR DENTURES
FR2961107B1 (en) HUMAN IMMUNOGLOBULIN COMPOSITION STABILIZED
IL240114A0 (en) B-cell lineage-based immunogen construct with human animals
EP2924048A4 (en) MUTANT RTRAIL AND MONOMETHYL AURISTATIN CONTEXT OF THE LATEST
EP2917174A4 (en) PREPARATION OF INTERMEDIATES OF X-RAY CONTRAST AGENTS
HRP20181799T1 (en) OPTIMIZED PHARMACEUTICAL FORMULA, INTENDED FOR THE TREATMENT OF INFLAMMATORY INFLAMMATORY CHANGE